COVID-19: A Message from Our CEO
"As the COVID-19 pandemic evolves, CSL remains committed to safeguarding our patients, our donors and our people. In keeping with our values-based culture, CSL has taken precautions to ensure our employees and our facilities remain safe so we can continue to deliver on our promise to patients and public health." - Paul Perreault, CEO & Managing Director, CSL LimitedRead Our Letter to Patients
Weathering the Storm After a Heart Attack
New analysis confirms the threat of recurrent heart attacks still persists.
Rare Disease in China
CSL Behring sponsors rare disease summit in China, where the rare disease community is trying to improve quality of life for …
Announcing Two New CSL Centenary Fellows
2021 winners study key proteins for clues on fighting global health challenges.
Watch Online: Swimming With the Dolphins
Find out how animal therapy works and why children who have Hemophilia B went for a swim with these friendly mammals in the F…
Getting to Know Jose Gonzalez
GM at CSL Behring’s Kankakee manufacturing facility looks back on an eventful first year.
Why Diversity Matters
Diversity is good for our people, it’s good for our business and it’s good for our patients.
The Family That Curls Together
Curling takes strategy, teamwork and a quick broom, says CSL Behring’s Brian Dudt, who coached his daughter's team to a natio…
What Is It Like to Have Sickle Cell Disease?
In their own words, patients and caregivers describe the disease’s emotional toll.
Ironman Athlete Takes On Primary Immunodeficiency
The race has changed, but marathoner Stacy Ahearn is still pushing ahead following a rare disease diagnosis at age 40.